I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
This clinical trial is designed to evaluate the efficacy and safety of the combination therapy of SP-8203 (Otaplimastat) and recombinant tissue Plasminogen Activator (rtPA) standard of care. In this clinical trial, rtPA will be injected intravenously using an infusion device. If reperfusion is not occur in spite of rtPA therapy, …
deficit
flair
stroke
brain mri
plasminogen activator
- 0 views
- 19 Feb, 2024